2 years ago
RXDX
Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
---|---|---|---|---|---|
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-12 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-04 - 2024-04-11 | Buy |
Adc Therapeutics SaADCT | +388.33% | $0.60 | $2.93 | 2023-11-07 - 2024-11-07 | Buy |
Nurix Therapeutics IncNRIX | +340.50% | $5.56 | $24.47 | 2023-11-01 - 2024-11-01 | Buy |
Alpine Immune Sciences IncALPN | +300.75% | $16.07 | $64.40 | 2023-11-02 - 2024-04-11 | Buy |
Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Spruce Biosciences IncSPRB | 13 | Hold | $0.50 | +320.17% | Maintains | 6 days ago |
Perspective Therapeutics IncCATX | 6 | Buy | $15.00 | +673.20% | Maintains | a month ago |
Cormedix IncCRMD | 6 | Buy | $12.00 | +56.45% | Reiterates | a month ago |
Verastem IncVSTM | 10 | Buy | $14.00 | +143.90% | Maintains | a month ago |
Inovio Pharmaceuticals IncINO | 10 | Hold | $5.00 | +187.36% | Maintains | a month ago |
Exelixis IncEXEL | 9 | Buy | $40.00 | +10.53% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 13 | Buy | $178.00 | +73.19% | Maintains | 2 months ago |
Nurix Therapeutics IncNRIX | 11 | Buy | $27.00 | +163.67% | Maintains | 3 months ago |
Amgen IncAMGN | 16 | Buy | $324.00 | +16.85% | Reiterates | 3 months ago |
Ideaya Biosciences IncIDYA | 12 | Buy | $61.00 | +257.14% | Reiterates | 3 months ago |
Pacira Biosciences IncPCRX | 11 | Hold | $18.00 | -26.98% | Reiterates | 3 months ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $48.00 | +1,109.07% | Maintains | 3 months ago |
Nuvation Bio IncNUVB | 6 | Buy | $10.00 | +407.61% | Reiterates | 3 months ago |
Mannkind CorpMNKD | 1 | Buy | $10.00 | +120.26% | Upgrades | 4 months ago |
Viridian Therapeutics IncVRDN | 11 | Buy | $47.00 | +257.96% | Maintains | 4 months ago |
Cidara Therapeutics IncCDTX | 1 | Buy | $34.00 | +74.90% | Initiates Coverage On | 4 months ago |
Agios Pharmaceuticals IncAGIO | 6 | Buy | $57.00 | +106.07% | Maintains | 4 months ago |
Cg Oncology IncCGON | 2 | Buy | $66.00 | +219.77% | Reiterates | 5 months ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $2.00 | +2,464.10% | Maintains | 5 months ago |
Fulcrum Therapeutics IncFULC | 3 | Hold | $4.00 | +21.58% | Reiterates | 5 months ago |
Verrica Pharmaceuticals IncVRCA | 7 | Hold | $2.00 | +308.16% | Downgrades | 6 months ago |
Bicycle Therapeutics PLCBCYC | 2 | Buy | $35.00 | +373.61% | Reiterates | 6 months ago |
Xencor IncXNCR | 8 | Buy | $34.00 | +250.52% | Maintains | 7 months ago |
Atyr Pharma IncATYR | 6 | Buy | $16.00 | +416.13% | Reiterates | 8 months ago |
Acadia Pharmaceuticals IncACAD | 13 | Buy | $26.00 | +76.51% | Maintains | 8 months ago |
Adc Therapeutics SaADCT | 11 | Buy | $8.00 | +561.16% | Reiterates | 8 months ago |
Morphic Holding IncMORF | 7 | Hold | $57.00 | +0.02% | Reiterates | 9 months ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | a year ago |
Fusion Pharmaceuticals IncFUSN | 3 | Hold | $21.00 | N/A | Downgrades | a year ago |
Aptose Biosciences IncAPTOF | 7 | Buy | $540.00 | N/A | Maintains | a year ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | N/A | Downgrades | 2 years ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | N/A | Reiterates | 2 years ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | N/A | Maintains | 2 years ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | 2 years ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 3 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 3 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 4 years ago |
Iterum Therapeutics PLCITRM | 3 | Hold | $30.00 | N/A | Downgrades | 5 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 5 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 5 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |